Elazar Rabbani's Net Worth
$8.96 Million
Who is Elazar Rabbani?
Elazar Rabbani has an estimated net worth of $8.96 Million. This is based on reported shares in ENZO BIOCHEM INC.
SEC CIK
Elazar Rabbani's CIK is 0000903568
Past Insider Trading and Trends
2011 was Elazar Rabbani's most active year for acquiring shares with 8 total transactions. Elazar Rabbani's most active month to acquire stocks was the month of December. 2004 was Elazar Rabbani's most active year for disposing of shares, totalling 20 transactions. Elazar Rabbani's most active month to dispose stocks was the month of March. 2004 saw Elazar Rabbani paying a total of $4,187,625.84 for 643,276 shares, this is the most they've acquired in one year. In 2004 Elazar Rabbani cashed out on 261,831 shares for a total of $3,100,673.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ENZO BIOCHEM INC (ENZ) Snapshot price: $1.11
CHIEF EXECUTIVE OFFICERElazar Rabbani owns 2,194,123 units of Common Stock, par value $.01 per share which is worth $2,435,476.53, 2,257,277 units of Restricted Stock Units which is worth $2,505,577.47, 2,262,208 units of Common Stock, par value $0.01 per share which is worth $2,511,050.88 and 1,661,003 units of Common Stock which is worth $1,843,713.33.acquired a total of 1,141,707 shares in ENZO BIOCHEM INC at a cost of $5,931,109.50, Elazar also disposed a total of 494,144 shares of ENZO BIOCHEM INC equalling to $5,598,224.65.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.17% | 190.11K |
—
|
—
| 2.26M |
Jan 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +0.17% | 2.78K |
$2.70 | $7,511.40 | 1.66M |
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +0.54% | 10K |
$3.35 | $33,469.00 | 1.85M |
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
| +0.55% | 9.97K |
$5.32 | -$110,244.10 | 1.84M |
Jan 17
| |||
Form 4
| +2.10% | 39.39K |
$6.55 | -$730,530.27 | 1.92M |
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| +0.95% | 20K |
$2.29 | $45,717.18 | 2.12M |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| +1.48% | 31.35K |
$8.36 | $3.19 | 2.16M |
Sep 23
| |||
Form 4
| +0.47% | 10.18K |
—
|
—
| 2.19M |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
| +0.67% | 15K |
—
|
—
| 2.26M |
Jan 23
| |||
Form 4
| +0.28% | 12.34K |
$12.25 | $5.63 | 4.39M |
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4/A
| +4.07% | 154.89K |
$11.79 | -$4.68 | 3.96M |
Apr 26
| |||
Form 4
| +4.06% | 154.89K |
$7.37 | $1,141,384.41 | 3.97M |
Apr 26
| |||
Form 4
| -0.01% | -3.33K |
$16.37 | -$54,426.91 | 37.99M |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
| No matching records found | |||||||||